The COVID-19 Early Treatment Fund (CETF) is an American non-profit organization created to support research using repurposed drugs in the prevention and treatment of COVID-19.
History
CETF was founded in April 2020 by Steve Kirsch.[1]
Personnel
| Name | Position | Notes |
|---|---|---|
| Steve Kirsch | Founder[1:1] | Vaccine Safety Research Foundation |
| Hilary Grant-Valdez | Chief of Staff[2] | Vaccine Safety Research Foundation, Token, M10 Networks, RePlatform, Kirsch Foundation |
Donors
Donors to the CETF include:[3]
- David Baszucki
- Jan Baszucki
- Lynne Benioff
- Marc Benioff
- Jon Burgstone
- Paul Cappuccio
- Vint Cerf
- Corrigan Walla Foundation
- Dharma Karma Foundation
- East Creek
- Edward J. Daly Foundation
- David Humm
- Michele Kirsch
- Steve Kirsch
- Leo Model Foundation
- Bill Losch
- Susanne Losch
- Melza & Frank Theodore Barr Foundation
- Mule Family Foundation
- Musk Foundation
- JaMel Perkins
- Tom Perkins
- Ravi & Naina Patel Foundation
- William Reller
- Skoll Foundation
- Jim Swartz
- Vanguard Charitable
External links
Further reading
- May 19, 2023: "Who Is David Boulware?" by Liam Sturgess
Saey, T. H. (2020, August 24). New treatments aim to treat COVID-19 early, before it gets serious. Science News. http://archive.today/2021.10.13-001342/https://www.sciencenews.org/article/coronavirus-covid-19-new-early-treatments ↩︎ ↩︎
About Us. RePlatform. Retrieved February 1, 2024, from http://archive.today/2024.02.01-235041/https://www.replatformvegas.com/about-us ↩︎
Donors. COVID-19 Early Treatment Fund. Retrieved September 29, 2021, from http://archive.today/2021.09.29-172054/https://www.treatearly.org/donors ↩︎
